Walker Paul Edward

10% owner at Korro Bio, Inc. · on record since Nov 7, 2023
10% owner at MBX Biosciences, Inc. · on record since Sep 17, 2024
Director at NeueHealth, Inc. · on record since Oct 6, 2025
10% owner at SpyGlass Pharma, Inc. · on record since Feb 11, 2026
Director at TESARO, Inc. · on record since Jun 27, 2012
Director at Tracon Pharmaceuticals, Inc. · on record since Jan 29, 2015
Director at Allakos Inc. · on record since Jul 18, 2018
Director at Marker Therapeutics, Inc. · on record since Oct 18, 2018
10% owner at Trevi Therapeutics, Inc. · on record since May 13, 2019
10% owner at Regulus Therapeutics Inc. · on record since May 10, 2019
Director at Regulus Therapeutics Inc. · on record since May 9, 2019
Director at Trevi Therapeutics, Inc. · on record since May 7, 2019
10% owner at Mirum Pharmaceuticals, Inc. · on record since Jul 24, 2019
10% owner at Black Diamond Therapeutics, Inc. · on record since Jan 29, 2020
10% owner at Akouos, Inc. · on record since Jun 25, 2020
10% owner at GENOCEA BIOSCIENCES, INC. · on record since Jul 28, 2020
10% owner at Metacrine, Inc. · on record since Sep 22, 2020
10% owner at Marker Therapeutics, Inc. · on record since Mar 18, 2021
Former 10% Owner at · on record since Mar 16, 2021
10% owner at · on record since Mar 16, 2021
Director at · on record since Jan 4, 2021
10% owner at · on record since Jun 30, 2021
10% owner at · on record since Jun 30, 2021

Insider trading activity of Walker Paul Edward

Transactions on record: 179; since Oct 17, 2012

Open-market buys: 23; $183.1M

Open-market sells: 17; $15.9M

Companies traded: 17; last filing Mar 12, 2026

Figures computed from official regulatory filings — .

Companies where Walker Paul Edward has traded

3 tx · $6M · Mar 12, 2026
15 tx · $40M · Feb 13, 2026
13 tx · $15M · Feb 11, 2026
57 tx · $372.8M · Oct 6, 2025
24 tx · $34.6M · May 15, 2025
5 tx · $8M · Sep 17, 2024
1 tx · $1M · Jul 19, 2023
7 tx · $6.8M · Jun 15, 2023
8 tx · $10M · Dec 2, 2022
4 tx · $8.3M · May 26, 2022
8 tx · $10.5M · Dec 27, 2021
5 tx · Nov 19, 2021
7 tx · $20M · Jun 30, 2021
1 tx · $10M · Mar 18, 2021

Track record of Walker Paul Edward

Statistical track record

Free account

Open-market buys: 50

Last buy: Mar 10, 2026

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Walker Paul Edward

Co-insiders of Walker Paul Edward

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Korro Bio, Inc.Listing on record	Mar 12, 2026	Buy	207,100	11.11 USD	$2.3M	conv 35Cluster	SEC
Korro Bio, Inc.Listing on record	Mar 12, 2026	BuyD (derivative)	242,945	11.11 USD	$2.7M	Cluster	SEC
Trevi Therapeutics, Inc.Listing on record	Feb 13, 2026	Other	1,851,852	1.37 USD	$2.5M		SEC
Trevi Therapeutics, Inc.Listing on record	Feb 13, 2026	OtherD (derivative)	-1,851,852	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	402,273	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-954,990	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	1,619,240	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Buy	937,500	16.00 USD	$15M	conv 48ClusterFirst in 12mo	SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	954,990	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-402,273	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-1,619,240	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-737,962	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	737,962	—	n/a (No price was disclosed in the filing)		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	AwardD (derivative)	124,085	—	n/a (No price was disclosed in the filing)		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	ExerciseD (derivative)	-372,255	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Sell	-280	6.75 USD	$1.9K		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Other	189,195	0.01 USD	$1.9K		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	OtherD (derivative)	-125,000	—	n/a (No price was disclosed in the filing)		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Other	-182	6.75 USD	$1.2K		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	OtherD (derivative)	-1,656,789	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	OtherD (derivative)	-189,195	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Korro Bio, Inc.Listing on record	Mar 12, 2026	Buy	207,100	11.11 USD	$2.3M	conv 35Cluster	SEC
Korro Bio, Inc.Listing on record	Mar 12, 2026	BuyD (derivative)	242,945	11.11 USD	$2.7M	Cluster	SEC
Trevi Therapeutics, Inc.Listing on record	Feb 13, 2026	Other	1,851,852	1.37 USD	$2.5M		SEC
Trevi Therapeutics, Inc.Listing on record	Feb 13, 2026	OtherD (derivative)	-1,851,852	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	402,273	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-954,990	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	1,619,240	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Buy	937,500	16.00 USD	$15M	conv 48ClusterFirst in 12mo	SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	954,990	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-402,273	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-1,619,240	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-737,962	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	737,962	—	n/a (No price was disclosed in the filing)		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	AwardD (derivative)	124,085	—	n/a (No price was disclosed in the filing)		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	ExerciseD (derivative)	-372,255	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Sell	-280	6.75 USD	$1.9K		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Other	189,195	0.01 USD	$1.9K		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	OtherD (derivative)	-125,000	—	n/a (No price was disclosed in the filing)		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Other	-182	6.75 USD	$1.2K		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	OtherD (derivative)	-1,656,789	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	OtherD (derivative)	-189,195	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC